IUCRO-0049; Immunological Genetic Molecular and pathological Correlates with Clinical and Treatment Outcome in Patients With Renal Cell Carcinoma
T
Theodore Logan, MD
Primary Investigator
Overview
The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information.
Description
The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Renal Cell Carcinoma
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria
Patients must have documented or suspected renal cell cancer.
Additional Information:Patients must have documented or suspected renal cell cancer.
Participants will not be paid for their participation.
Updated on
23 Apr 2024.
Study ID: 1011004244 (0311-39)